3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
Meet Veristat at DIA Canada Annual Meeting 2024
Discover what makes Veristat a distinguished name in the industry.
Veristat is a scientific-minded global clinical research organization (CRO) and consultancy that integrates full-service clinical trial execution, regulatory consulting, and strategic planning to accelerate the development, approval, and commercialization of revolutionary therapies around the globe.
Join Veristat at the DIA Canada Annual Meeting, November 14-15, 2024, at the Hilton Lac-Leamy in Gatineau, Quebec. This premier event brings together life sciences professionals across regulatory affairs, clinical development, and pharmacovigilance to explore industry developments and best practices.
Our experienced team of experts looks forward to discussing how Veristat can support your clinical research and regulatory needs in the Canadian market and beyond.
Veristat Attendees:
Azim Ladha, Senior Business Development Director
Anna Bussel, Director, Pharmacovigilance & Medical Information
Manisha Rohit, Associate Director, Pharmacovigilance & Medical Information
Conference Details:
Date: November 14-15, 2024
Time: 7:30 AM - 4:10 PM
Location: Hilton Lac-Leamy 3 Boulevard du Casino Gatineau, QC J8Y 6X4 Canada
Schedule a Meeting:
Fill out the form to schedule a meeting with our experts.
Learn how Veristat can support you in driving your upcoming clinical trials, regulatory submissions, and pharmacovigilance programs toward successful outcomes.
Learn more about the conference
3 min read
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...